Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

Blood

Volumn 101, Issue 9, 2003, Pages 3386-3390

  Matsushima, Takafumi ^a   Handa, Hiroshi ^b   Yokohama, Akihiko ^b   Nagasaki, Jun ^b   Koiso, Hiromi ^b   Kin, Yoshitora ^b   Tanaka, Yoko ^b   Sakura, Tohru ^b   Tsukamoto, Norifumi ^b   Karasawa, Masamitsu ^b   Itoh, Katsuhiko ^b   Hirabayashi, Hisami ^b   Sawamura, Morio ^b   Shinonome, Shogo ^b   Shimano, Shun Ichi ^b   Miyawaki, Shuichi ^b   Nojima, Yoshihisa ^b   Murakami, Hirokazu ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BASOPHILIA; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; EOSINOPHILIA; FEMALE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; ACUTE DISEASE; ADOLESCENT; BASOPHIL; BONE MARROW; CLASSIFICATION; DISEASE COURSE; GENETICS; HOSPITALIZATION; JAPAN; LEUKOCYTE COUNT; LIFE TABLE; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; REVIEW; SURVIVAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASOPHILS; BONE MARROW; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; EOSINOPHILIA; FEMALE; HUMANS; JAPAN; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; LIFE TABLES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0037866468     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0947     Document Type: Article

References (35)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
2. Morel P, Hebbar M, Lai JL, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia. 1993;7:1315-1323.
3. Toyama K, Ohyashiki K, Yoshida Y, et al. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia. 1993;7:499-508.
4. Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia. 1992;6:52-59.
5. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol. 1985;59:425-433.
6. Sanz GF, Sanz MA, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivadate analysis of prognostic factors in 370 patients. Blood. 1989;74:395-408.
7. Cassano E, Giordano M, Riccardi A, Coci A, Cazzola M. Myelodysplastic syndromes: a multiparametric study of prognostic factors and a proposed scoring system. Haematologica. 1990;75:141-145.
8. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
9. Matsushima T, Murakami H, Sawamura M, et al. Myelodysplastic syndrome with eosinophilia in bone marrow. Br J Haematol. 1993;84:636-638.
10. Ryan DH. Examination of the marrow. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. 6th ed. New York, NY: McGraw-Hill; 2001:17-25.
11. el Rifai W, Pettersson T, Larramendy ML, Knuutila S. Lineage involvement and karyotype in a patient with myelodysplasia and blood basophilia. Eur J Haematol. 1994;53:288-292.
12. Bakotic BW, Poniecka AW, Dominguez CJ, Benigno A, Donahue RP, Cabello-Inchausti B. Myelodysplastic syndrome with atypical eosinophilia in association with ring chromosome 7. Cancer Genet Cytogenet. 1999;115:19-22.
13. Sole F, Torrabadella M, Granada I, et al. Isochromosome 17q as a sole anomaly: a distinct myelodysplastic syndrome entity? Leuk Res. 1993;17:717-720.
14. Cuneo A, Kerim S, Vandenberghe E, et al. Translocation t(6;9) occurring in acute myelofibrosis, myelodysplastic syndrome, and acute nonlymphocytic leukemia suggests multipotent stem cell involvement. Cancer Genet Cytogenet. 1989;42:209-219.
15. Fan YS, Raza A, Schumer J, et al. Translocation t(6;9)(p22.3;q34) in myelodysplastic syndrome refractory anemia with excess blasts. Cancer Genet Cytogenet. 1987;29:135-138.
16. Shapira MY, Hishberg B, Amir G, Rund D. 6;9 translocation in myelodysplastic syndrome. Cancer Genet Cytogenet. 1999;112:57-59.
17. Neri G, Daniel A, Hammond N. Chromosome 16q, eosinophilia, and leukemia. Cancer Genet Cytogenet. 1985;14:371-372.
18. Abbondanzo SL, Gray RG, Whang-Peng J, Jacobson J. A myeolodysplastic syndrome with marrow eosinophilia terminating in acute nonlymphocytic leukemia, associated with an abnormal chromosome 16. Arch Pathol Lab Med. 1987;111:330-332.
19. Horiike S, Misawa S, Nishida K, et al. Myelodysplastic syndrome preceding acute myelomonocytic leukemia with dysplastic marrow eosinophilia and Inv(16). Acta Haemat. 1989:82:161-164.
20. Brain BJ. Eosinophilic leukaemia and idiopathic hypereosinophilic syndrome. Br J Haematol. 1996;95:2-9.
21. Follows GA, Owen RG, Ashcroft AJ, Parapia LA. Eosinophilic myelodysplasia transforming to acute lymphoblastic leukemia. J Clin Pathol. 1999;52:388-389.
22. Kobayashi H, Kitano K, Shimodaira S, et al. Eosinophilia in myelodysplastic syndrome with a (12;21)(q23;q22) translocation. Cancer Genet Cytogenet. 1993;68:95-98.
23. Matsushima T, Murakami H, Kim K, et al. Steroid-responsive pulmonary disorders associated with myelodysplastic syndromes with der(1q;7p) chromosomal abnormality. Am J Hematol. 1995;50:110-115.
24. Imai Y, Yasuhara S, Hanafusa N, et al. Clonal involvement of eosinophils in therapy-related myelodysplastic syndrome with eosinophilia, translocation t(1;7) and lung cancer. Br J Haematol. 1996;95:710-714.
25. Saigo K, Sugimoto T, Ryo R, Yamaguchi N. Hematologic improvement by alpha-interferon in a case of the 5q-syndrome with basophilia and eosinophilia [in Japanese]. Rinsho Ketsueki. 1995;36:18-22.
26. Shirakawa C, Ohno M, Sugishima H, et al. Overt leukemia from MDS associated with marked basophilia [in Japanese]. Rinsho Ketsueki. 1992;33:1031-1035.
27. Tinegate HN, Chetty MN. Basophilia as a feature of the myelodysplastic syndrome. Clin Lab Haematol. 1986;8:269-271.
28. Keene P, Mendelow B, Pinto MR, et al. Abnormalities of 12p13 and malignant proliferation of eosinophils: a nonrandom association. Br J Haematol. 1987;67:25-31.
29. Ma SK, Wong KF, Chan JK, Kwong YL. Refractory cytopenia with t(1;7), +8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study. Br J Haematol. 1995;90:216-218.
30. Pérez-Losada A, Woessner S, Sole F, Florensa L, Granesa A. Refractory anemia with hypereosinophilia and clonal abnormal metaphases detected in the neutrophil granulopoietic series. Acta Haematol. 1994;91:80-83.
31. Jani K, Kempski HM, Reeves BR. A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils. Br J Haematol. 1994;87:57-60.
32. Ross FM. Hamilton M, Cook MK, Irving JB. A myelodysplastic syndrome with eosinophilia associated with a break in the short arm of chromosome 16. Leukemia. 1987;1:680-681.
33. Forrest DL, Horsman DE, Jensen CL, et al. Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): confirmation of eosinophil clonal involvement by fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998;107:65-68.
34. Kwong YL, Chan LC. Involvement of eosinophils in acute myeloid leukemia with monosomy 7 demonstrated by fluorescence in situ hybridization. Br J Haematol. 1994;88:389-391.
35. Murakawa M, Shibuya T, Taniguchi S, et al. Acute eosinophilic leukemia in a patient with preexistent myelodysplastic syndrome. Acta Haematol. 1991;86:42-45.